INDIAN BENCHMARK have rebounded in trades and have started the July series on a higher note.
FURTHER, Coal India has signed fuel supply pacts with power plants for a capacity of 73,075 MW. Ranbaxy Laboratories received the US Food and Drug Administration approval to sell a generic version of Novartis’s hypertension medicine Diovan
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 433cr, as per the provisional figures released by the NSE.
FURTHER, Coal India has signed fuel supply pacts with power plants for a capacity of 73,075 MW. Ranbaxy Laboratories received the US Food and Drug Administration approval to sell a generic version of Novartis’s hypertension medicine Diovan
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 433cr, as per the provisional figures released by the NSE.
For more detail contact us: 0731-6790000,6669900
Click Here: capitalstars.com
Click Here: capitalstars.com
0 Comments